Veronica Sanchez Bulis

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Mark Meltz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Veronica Sanchez Bulis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. VP, Corporate Controller Common Stock 7,141 $230,797 $32.32 30 Dec 2025 Direct

Insider Reports Filed by Veronica Sanchez Bulis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYEL Lyell Immunopharma, Inc. 24 Dec 2025 2 -$74,181 4 VP, Corporate Controller 06 Jan 2026, 16:02
LYEL Lyell Immunopharma, Inc. 10 Nov 2025 1 -$3,848 4 VP, Corporate Controller 12 Nov 2025, 20:34
LYEL Lyell Immunopharma, Inc. 31 Oct 2025 0 $0 3 VP, Corporate Controller 10 Nov 2025, 21:07